Lakefront Biotherapeutics | GLPG - Ativos





Ativos Alterar Data
argenx SE USD 8.68B 1.51B 2025-12
AstraZeneca USD 114.02B 59M 2026-03
Biogen USD 29.48B 43.6M 2026-03
Genmab DKK 12.87B 5.85B 2025-12
Gilead Sciences USD 56.28B 2.74B 2026-03
GlaxoSmithKline GBP 62.87B 1.75B 2026-03
GRIFOLS EUR 20.08B 366M 2026-03
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Incyte USD 7.34B 381.14M 2026-03
Merck EUR 53.07B 1.54B 2026-03
Neurocrine Biosciences USD 4.91B 274.7M 2026-03
Novartis USD 118.53B 7.58B 2026-03
Roche Holding CHF 100.7B 5.94B 2025-12
Sanofi EUR 128.02B 1.22B 2026-03
UCB EUR 18.16B 971M 2025-12
Vertex Pharmaceuticals USD 26.48B 841.4M 2026-03